profit from every €100 of sales.
€0€100
Ottobock SE & Co. KGaA
€39.20-16.60% today
-35.5% since Jan 25, 26
1-year low €39.201-year high €62.70
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
You pay €27.81 for every €1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Ottobock SE & Co. KGaA vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from €100 of sales | Sales growth a year | Price per €1 of profit |
|---|---|---|---|
| Ottobock SE & Co. KGaA | 27.8× · Fair price | ||
 Intuitive Surgical | 53.4× · Expensive | ||
 EssilorLuxottica Société anonyme | 35.6× · Expensive | ||
 Becton, Dickinson and | 35.0× · Expensive | ||
 Medline | 45.4× · Expensive |
AI analysis
An AI analyst reads Ottobock SE & Co. KGaA's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of EUR | 2025 |
|---|---|
| 1,680 | |
| 887 | |
| 233 | |
| 381 | |
| 90 | |
| 1.41 | |
| 52.8% | |
| 13.9% | |
| 5.4% |
Balance sheet
| In millions of EUR | 2025 |
|---|---|
| Total assets | 2,050 |
| Cash | 90 |
| Total debt | 1,051 |
| Total liabilities | 1,652 |
| 390 | |
| 64 | |
| 10.2% | |
| 23.1% |
Cash flow
| In millions of EUR | 2025 |
|---|---|
| 333 | |
| 109 | |
| 225 | |
| Dividends paid | 15 |
| – | |
| – |
Valuation
- 27.8×
- –
- –
- 8.3×
- 1.5×
- 11.2×
- 9.1×
- 8.9%
- 3.6%
- 0.6%
Profitability
- 52.8%
- 13.9%
- 5.4%
- –
- 10.2%
- 10.2%
- –
- –
- –
- –
Growth
- –
- –
- –
- –
- +0.0%
Financial health
- 2.5×
- 2.69
- –
- 3.5×
- 0.95
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 30%of 952
Top 38%of 883
Top 50%of 576
Top 10%of 985
0.6%of the share price, paid each year
On $1,000 invested$6a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
16.7% of its profit
Room to growStretchedMore than it earns: 6.7%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
55No pass
Benjamin Graham
30No pass
Philip Fisher
55No pass
Peter Lynch
26No pass
Joel Greenblatt
31No pass
Charlie Munger
40No pass
Terry Smith
44No pass
Questions about Ottobock SE & Co. KGaA
Is Ottobock SE & Co. KGaA a good stock to buy?
A business with weak numbers at a fair price. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Ottobock SE & Co. KGaA AI analysis
What does Ottobock SE & Co. KGaA do?
Ottobock SE & Co. It is in Medical Instruments & Supplies, based in Duderstadt, Germany, with 8,606 employees.
Does Ottobock SE & Co. KGaA pay a dividend?
Yes. At today's price the dividend is 0.6% a year, about 17% of its yearly profit. In 2025 it paid out €15.1 million in dividends.
Is Ottobock SE & Co. KGaA stock halal?
No. Ottobock SE & Co. KGaA does not pass our halal screen: its debt is 42% of its market value, at or above the 33% limit. How we check
Who are Ottobock SE & Co. KGaA's competitors?
The largest listed companies in the same industry are Intuitive Surgical, EssilorLuxottica Société anonyme, Becton, Dickinson and and Medline. The peers table on this page compares their profit, growth and price with Ottobock SE & Co. KGaA's.
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.